Picture of HAVN Life Sciences logo

HAVN HAVN Life Sciences Cashflow Statement

0.000.00%
ca flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Annual cashflow statement for HAVN Life Sciences, fiscal year end - April 30th, CAD millions except per share, conversion factor applied.

2020
April 30th
2021
April 30th
2022
April 30th
Period Length:12 M12 M12 M
Source:ARSARSARS
Standards:
IFRS
IFRS
IFRS
Status:FinalFinalFinal
Net Income/Starting Line-0.041-30.4-22.4
Depreciation
Non-Cash Items-0.0011614.5
Unusual Items
Other Non-Cash Items
Changes in Working Capital-0.034-0.615-0.536
Change in Accounts Receivable
Change in Prepaid Expenses
Change in Payable / Accrued Expenses
Cash from Operating Activities-0.075-10.4-7.88
Capital Expenditures-0.033-0.103
Purchase of Fixed Assets
Other Investing Cash Flow Items-0.25-0.364-1.93
Acquisition of Business
Sale of Fixed Assets
Other Investing Cash Flow
Cash from Investing Activities-0.25-0.397-2.03
Financing Cash Flow Items0.02-1.16-0.335
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities1.9418.61.56
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash1.627.78-8.35